E. Southam et al., LAMOTRIGINE INHIBITS MONOAMINE UPTAKE IN-VITRO AND MODULATES 5-HYDROXYTRYPTAMINE UPTAKE IN RATS, European journal of pharmacology, 358(1), 1998, pp. 19-24
Lamotrigine is a novel anticonvulsant drug which also stabilises mood
in bipolar illness via an unknown mechanism. We report the concentrati
on-dependent inhibition of 5-hydroxytryptamine (5-HT) uptake in both h
uman platelets and rat brain synaptosomes (IC50 were 240 and 474 mu M,
respectively) by lamotrigine. Synaptosomal uptake of noradrenaline (I
C50 239 mu M) and dopamine (IC50 322 mu M) was also inhibited. Tetrodo
toxin failed to modulate 5-HT uptake suggesting that sodium channel bl
ockade does not mediate the lamotrigine effect. Lithium, sodium valpro
ate, zonisamide, and carbamazepine all possess anti-manic activity but
only the latter inhibited 5-HT uptake. The inhibition of the p-chloro
amphetamine-induced 5-HT syndrome in rats suggests that lamotrigine al
so inhibits 5-HT uptake in vivo. These effects probably reflect an aff
inity for biogenic amine transporters. However, at present, it remains
uncertain whether, at clinically effective doses, these effects contr
ibute significantly to the efficacy of lamotrigine in bipolar illness.
(C) 1998 Elsevier Science B.V. All rights reserved.